Mitotic phosphorylation of SOX2 mediated by Aurora kinase A is critical for the stem-cell like cell maintenance in PA-1 cells

References

• Bylund M, Andersson E, Novitch BG, Muhr J. Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nat Neurosci 2003; 6:1162-8; PMID:14517545; http://dx.doi.org/10.1038/nn1131
   PubMed Web of Science ®Google Scholar
• Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448:313-7; PMID:17554338; http://dx.doi.org/10.1038/nature05934
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-72; PMID:18035408; http://dx.doi.org/10.1016/j.cell.2007.11.019
   PubMed Web of Science ®Google Scholar
• Kopp JL, Ormsbee BD, Desler M, Rizzino A. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 2008; 26:903-11; PMID:18238855; http://dx.doi.org/10.1634/stemcells.2007-0951
   PubMed Web of Science ®Google Scholar
• Chew JL, Loh YH, Zhang W, Chen X, Tam WL, Yeap LS, Li P, Ang YS, Lim B, Robson P, et al. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 2005; 25:6031-46; PMID:15988017; http://dx.doi.org/10.1128/MCB.25.14.6031-6046.2005
   PubMed Web of Science ®Google Scholar
• Gao Z, Cox JL, Gilmore JM, Ormsbee BD, Mallanna SK, Washburn MP, Rizzino A. Determination of protein interactome of transcription factor Sox2 in embryonic stem cells engineered for inducible expression of four reprogramming factors. J Biol Chem 2012; 287:11384-97; PMID:22334693; http://dx.doi.org/10.1074/jbc.M111.320143
   PubMed Web of Science ®Google Scholar
• Mallanna SK, Ormsbee BD, Iacovino M, Gilmore JM, Cox JL, Kyba M, Washburn MP, Rizzino A. Proteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate. Stem Cells 2010; 28:1715-27; PMID:20687156; http://dx.doi.org/10.1002/stem.494
   PubMed Web of Science ®Google Scholar
• Van Hoof D, Munoz J, Braam SR, Pinkse MW, Linding R, Heck AJ, Mummery CL, Krijgsveld J. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009; 5:214-26; PMID:19664995; http://dx.doi.org/10.1016/j.stem.2009.05.021
   PubMed Web of Science ®Google Scholar
• Tsuruzoe S, Ishihara K, Uchimura Y, Watanabe S, Sekita Y, Aoto T, Saitoh H, Yuasa Y, Niwa H, Kawasuji M, et al. Inhibition of DNA binding of Sox2 by the SUMO conjugation. Biochem Biophys Res Commun 2006; 351:920-6; PMID:17097055; http://dx.doi.org/10.1016/j.bbrc.2006.10.130
   PubMed Web of Science ®Google Scholar
• Wu Y, Guo Z, Wu H, Wang X, Yang L, Shi X, Du J, Tang B, Li W, Zhang Y. SUMOylation represses Nanog expression via modulating transcription factors Oct4 and Sox2. PLoS One 2012; 7:e39606; PMID:22745796; http://dx.doi.org/10.1371/journal.pone.0039606
   PubMedGoogle Scholar
• Zhao HY, Zhang YJ, Dai H, Zhang Y, Shen YF. CARM1 mediates modulation of Sox2. PLoS One 2011; 6:e27026; PMID:22046437; http://dx.doi.org/10.1371/journal.pone.0027026
   PubMedGoogle Scholar
• Fang L, Zhang L, Wei W, Jin X, Wang P, Tong Y, Li J, Du JX, Wong J. A methylation-phosphorylation switch determines Sox2 stability and function in ESC maintenance or differentiation. Mol Cell 2014; 55:537-51; PMID:25042802; http://dx.doi.org/10.1016/j.molcel.2014.06.018
   PubMed Web of Science ®Google Scholar
• Justilien V, Walsh MP, Ali SA, Thompson EA, Murray NR, Fields AP. The PRKCI and Sox2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Cancer Cell 2014; 25:139-51; PMID:24525231; http://dx.doi.org/10.1016/j.ccr.2014.01.008
   PubMed Web of Science ®Google Scholar
• Ouyang J, Yu W, Liu J, Zhang N, Florens L, Chen J, Liu H, Washburn M, Pei D, Xie T. Cyclin-Dependent Kinase-mediated Sox2 phosphorylation enhances the ability of Sox2 to establish the pluripotent State. J Biol Chem 2015; 290:22782-94; PMID:26139602; http://dx.doi.org/10.1074/jbc.M115.658195
   PubMed Web of Science ®Google Scholar
• Fu J, Bian M, Jiang Q, Zhang C. Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 2007; 5:1-10; PMID:17259342; http://dx.doi.org/10.1158/1541-7786.MCR-06-0208
   PubMed Web of Science ®Google Scholar
• Fu J, Bian M, Liu J, Jiang Q, Zhang C. A single amino acid change converts Aurora-A into Aurora-B-like kinase in terms of partner specificity and cellular function. Proc Natl Acad Sci U S A 2009; 106:6939-44; PMID:19357306; http://dx.doi.org/10.1073/pnas.0900833106
   PubMed Web of Science ®Google Scholar
• Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, Graham JA, Demur C, Hercend T, Diu-Hercend A, et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 2014; 10:262-7; http://dx.doi.org/10.1038/nm1003
   Web of Science ®Google Scholar
• Yin F, Lan R, Zhang X, Zhu L, Chen F, Xu Z, Liu Y, Ye T, Sun H, Lu F, et al. LSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16. Mol Cell Biol 2014; 34:158-79; PMID:24190971; http://dx.doi.org/10.1128/MCB.00631-13
   PubMed Web of Science ®Google Scholar
• Du L, Yang Y, Xiao X, Wang C, Zhang X, Wang L, Li W, Zheng G, Wang S, Dong Z. Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma. Oral Oncol 2011; 47:709-13; PMID:21689966; http://dx.doi.org/10.1016/j.oraloncology.2011.05.017
   PubMed Web of Science ®Google Scholar
• Zhang X, Lu F, Wang J, Yin F, Xu Z, Qi D, Wu X, Cao Y, Liang W, Liu Y, et al. Pluripotent stem cell protein Sox2 confers sensitivity to LSD1 inhibition in cancer cells. Cell Rep 2014; 5:445-57; http://dx.doi.org/10.1016/j.celrep.2013.09.018
   Web of Science ®Google Scholar
• Wang J, Lu F, Ren Q, Sun H, Xu Z, Lan R, Liu Y, Ward D, Quan J, Ye T, et al. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Res 2011; 71:7238-49; PMID:21975933; http://dx.doi.org/10.1158/0008-5472.CAN-11-0896
   PubMed Web of Science ®Google Scholar
• Taira N, Mimoto R, Kurata M, Yamaguchi T, Kitagawa M, Miki Y, Yoshida K. DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. J Clin Invest 2012; 122:859-72; PMID:22307329; http://dx.doi.org/10.1172/JCI60818
   PubMed Web of Science ®Google Scholar
• Ding D, Xu H, Liang Q, Xu L, Zhao Y, Wang Y. Overexpression of Sox2 in C3H10T1/2 cells inhibits osteoblast differentiation through Wnt and MAPK signalling pathways. Int Orthop 2011; 36:1087-94; PMID:22012572; http://dx.doi.org/10.1007/s00264-011-1368-6
   PubMed Web of Science ®Google Scholar
• Ichida JK, Blanchard J, Lam K, Son EY, Chung JE, Egli D, Loh KM, Carter AC, Di Giorgio FP, Koszka K, et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009; 5:491-503; PMID:19818703; http://dx.doi.org/10.1016/j.stem.2009.09.012
   PubMed Web of Science ®Google Scholar
• Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008; 3:568-74; PMID:18983970; http://dx.doi.org/10.1016/j.stem.2008.10.004
   PubMed Web of Science ®Google Scholar
• Li X, Zuo X, Jing J, Ma Y, Wang J, Liu D, Zhu J, Du X, Xiong L, Du Y, et al. Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons. Cell Stem Cell 2015; 17:195-203; PMID:26253201; http://dx.doi.org/10.1016/j.stem.2015.06.003
   PubMed Web of Science ®Google Scholar
• Jeong CH, Cho YY, Kim MO, Kim SH, Cho EJ, Lee SY, Jeon YJ, Lee KY, Yao K, Keum YS, et al. Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells. Stem Cells 2010; 28:2141-50; PMID:20945330; http://dx.doi.org/10.1002/stem.540
   PubMed Web of Science ®Google Scholar
• Aliagas-Martin I, Burdick D, Corson L, Dotson J, Drummond J, Fields C, Huang OW, Hunsaker T, Kleinheinz T, Krueger E, et al. A class of 2, 4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B. J Med Chem 2009; 52:3300-7; PMID:19402633; http://dx.doi.org/10.1021/jm9000314
   PubMed Web of Science ®Google Scholar
• Lan R, Lin G, Yin F, Xu J, Zhang X, Wang J, Wang Y, Gong J, Ding YH, Yang Z, et al. Dissecting the phenotypes of Plk1 inhibition in cancer cells using novel kinase inhibitory chemical CBB2001. Lab Invest 2012; 92:1503-14; PMID:22890557; http://dx.doi.org/10.1038/labinvest.2012.114
   PubMed Web of Science ®Google Scholar
• Qi D, Wang Q, Li H, Zhang T, Lan R, Kwong D, Wong W, Wong K, Li S, Lu F. SILAC-based quantitative proteomics identified lysosome as a fast response target to PDT agent Gd-N induced oxidative stress in human ovarian cancer IGROV1 cells. Mol Bio Syst 2015; 11:3059-67
   Google Scholar
• Dephoure N, Gould KL, Gygi SP, Kellogg DR. Mapping and analysis of phosphorylation sites: a quick guide for cell biologists. Mol Biol Cell 2013; 24:535-42; PMID:23447708; http://dx.doi.org/10.1091/mbc.E12-09-0677
   PubMed Web of Science ®Google Scholar
• Savitski MM, Lemeer S, Boesche M, Lang M, Mathieson T, Bantscheff M. and Kuster B. Confident phosphorylation site localization using the Mascot Delta Score. Mol Cell Proteomics 2011; 10:M110.003830; PMID:21057138; http://dx.doi.org/10.1074/mcp.M110.003830
   PubMed Web of Science ®Google Scholar